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CD44 may mediate adhesion between bone marrow (BM) progenitor cells and stromal cells, 7,9 which express high lev-D44 IS A HYALURONAN-binding surface receptor present on lymphocytes and other cells of hematopoietic and nonhematopoietic origins. CD44 is implicated in a els of the CD44 ligand, fibronectin. The interaction with stromal cells is important for survival and differentiation variety of immunological functions, such as vascular extravasation and T-cell costimulation, although broad tissue exof hematopoietic progenitors. This has been shown using monoclonal antibodies (MoAbs) against CD44 in Dexterpression of CD44 isoforms and their upregulation at various stages during development has also suggested a variety of type long-term BM cultures, in which the antibodies have been shown to prevent emergence of myeloid cells. 7 other important nonimmunological roles. There is evidence that CD44 may be involved in tumor metastasis, [1] [2] [3] and high CD44 isoforms are encoded by a single gene containing 19 or 20 exons, 12 of which can be differentially spliced. All levels of CD44 expression on embryonic cells has suggested a role in embryogenesis. [4] [5] [6] During critical stages of morphoknown membrane-associated CD44 isoforms have 5 constant exons at the amino terminus followed by 10 alternatively genesis, CD44 is expressed at high levels in developing heart, somites, and condensing limb-bud mesenchyme. In spliced exons, 2 constant membrane-proximal coding exons, 1 constant transmembrane-coding exon, and 2 potentially these tissues hyaluronate has been found to regulate morphogenetic events, 4-6 increasing the possibility that CD44 might alternatively spliced exons coding for cytoplasmic domains. The great variability in splicing leads to at least 18 different play a critical role during embryogenesis.
Various reports have implicated CD44 in the development CD44 isoforms, 40 ,41 some preferentially expressed in certain and function of the immune system. Hematopoietic cells express CD44 in a temporally regulated manner.
7-11 CD44 cells of mesenchymal and neuroectodermal origin, including taining fibroblasts. Taken together, our investigations of gene-targeted mice implicate the CD44 molecule as a regulakeratinocytes and fibroblasts [42] [43] [44] and hematopoietic cells, astrocytes, and glial cells, [45] [46] [47] [48] respectively. Independently tor of hematopoietic progenitor distribution and of immune responses to granuloma-inducing bacteria. We also provide cloned by several groups, CD44H, also called CD44s, is the most common isoform and the major receptor for hyaluronic unequivocal findings of CD44 involvement in tumor growth. acid (HA) on hematopoietic cells and fibroblasts. [49] [50] [51] [52] [53] 
MATERIALS AND METHODS

CD44 binding capacity for HA correlates with the level
Generation of the CD44 mutant mice. The targeting construct of cell activation and can require phosphorylation of one of was generated as follows: A polymerase chain reaction (PCR)-amplitwo cytoplasmic serine residues or CD44 dimerization. 54, 55 fied probe containing CD44 exons 2 and 3 was used to screen a All known membrane-bound CD44 molecules contain a ser-129J-l DashII genomic library (kindly provided by Dr Janet Rossant, ine-threonine-rich ''mucin-like domain'' located between Toronto, Canada). Five phage clones were selected and partially the amino-terminal HA-binding motif and the transmemmapped. One of these clones, containing 15 kb of genomic CD44 brane region that can be highly O-linked glycosylated. Ansequence including exons 2 and 3, was transferred into pBlue script other element encoded by the two invariant exons are four (BS-SK; Stratagene, La Jolla, CA) for mapping and partial sequencserine-glycine residues, believed to be potential sites for proing. The 3 region of exon 2 and the complete exon 3 were replaced with pMC1-Neomycin (pMC1-neo; Stratagene). The 5 short arm teoglycan substitutions. [56] [57] [58] [59] [60] More recent data show that the consisted of a 600-bp Nco I-fragment of exon 2 containing its first majority of chondroitin-and heparin-sulfate modifications 122-bp (of a total of 160 bp) blunt end ligated to pMC1-neo. The require the presence of the variable exon v3. 56, 58 pMC1 neo fragment used was originally isolated with Xho I and
Since it was reported that an alternative spliced form of
HindIII and contains a polyadenylation signal. For the 3 long arm, CD44 could confer metastatic capacity to a rat pancreatic a 6-kb intronic region 3 of exon 3 isolated with Kpn I digestion carcinoma cell line, 3 a large amount of work has been pubwas chosen. It should be noted that pMC1-neo was inserted in the lished with regard to the role of CD44 in tumor progression antisense orientation, which leads to several stop codons in all three and metastasis. [61] [62] [63] [64] Therefore, we decided to investigate the reading frames. The construct was linearized at the 5 end of the tumorigenicity of SV40 large T-transformed fibroblast deshort arm using the BS-SK restriction site Not I, and 25 mg digested rived from CD44-deficient mice. We report here that these DNA was electroporated into 2 1 10 6 E14 embryonic stem cells (Bio-Rad Gene Pulser, 340 V, 250 mF; Bio-Rad Laboratories, Hercells are significantly more tumorigenic than CD44s-conFor personal use only. on November 11, 2017 . by guest www.bloodjournal.org From cules, CA). Colonies resistant to G418 were screened for homologous recombination by PCR as described. 65 The following primers were used : upstream of the targeting vector, 5-TGG TCT TGA  ACT CAG GTG ATC CTC-3 and 5-TAT CAG GAC ATA GCG  TTG GCT ACC C-3. The PCR amplification conditions were 5  minutes at 94ЊC, 1 minute at 94ЊC, 30 seconds at 64ЊC, and 2 minutes  at 72ЊC for 35 cycles. Recombinant colonies were confirmed by Southern blotting and injected into 3.5-day-old C57Bl/6J blastocysts, which were then transferred into 2.5-day pseudopregnant CD1 foster mothers as previously described. [65] [66] [67] Chimeras were backcrossed into C57Bl/6J or CB6F1 mice (both from Jackson Laboratories, Bar Harbor, ME), and agouti offspring were screened by Southern blot analysis.
Southern blot analysis to identify targeted clones and to genotype mice. Individual embryonic stem cells (ES) clones and mouse tails were lysed in 100 mmol/L NaCl, 10 mmol/L Tris/HCl pH 8.0, 1 mmol/L EDTA, 1% sodium dodecyl sulfate (SDS), 150 mg/mL proteinase K (Sigma, St Louis, MO), 1 mg/mL self-digested Pronase E (Sigma) overnight at 37ЊC. Debris was removed by rapid centrifugation. Samples were extracted in phenol-chloroform and DNA was isolated by ethanol precipitation. Genomic DNA (10 mg) was digested with KpnI, resolved on 0.8% agarose gels, and transferred to nylon membranes (Hybond N / ) by using standard transfer procedures. Prehybridization and hybridization were performed in 0.5 mol/ L sodium phosphate buffer (pH 7.0), 7% SDS, 1 mmol/L EDTA, 1% bovine serum albumin (BSA), and 100 mg/mL salmon sperm DNA at 65ЊC. Probes were radiolabeled with 32 P-dCPT by using the Multiprime DNA Labeling System (Amersham, Arlington Heights, IL) following the manufacturers instructions. Filters were washed twice in 50 mmol/L sodium phosphate buffer (pH 7.0), 1% SDS, 1 mmol/L EDTA, 0.5% BSA, and twice without BSA at 65ЊC. Washed filters were exposed on phosphorimager screens and analyzed on a phosphorimager analyzer (Molecular Dynamics, Sunnyvale, CA). A 500-bp KpnI fragment upstream of exon 2 was used as a flanking probe (Fig 1) . For further confirmation, DNA from all ES cell clones was digested with several restriction enzymes and hybridized to probes for the neomycin coding region.
Flow cytometric analyses. The following MoAbs were used: anti-CD44 phycoerythrin (PE; clone IM7; Pharmingen, San Diego, CA), anti-CD44-PE (clone KM 201; Southern Biotechnology, Birmingham, AL), CD44 clone KM81 and clone KM114 (both obtained from American Type Culture Collection, Rockville, MD), anti- granulocyte colony-stimulating factor (G-CSF) from Amgen (125 Iscove's modified Dulbecco's medium supplemented with fetal bovine serum, 2-mercaptoethanol (2-ME) and either recombinant mg/kg body weight) diluted in PBS. Control mice received PBS only. At day 7, peripheral blood (PB), BM, and spleen cells were interleukin-3 (IL-3), erythropoietin (EPO), macrophage colony-stimulating factor (M-CSF), or supernatant containing IL-1, IL-3, ILisolated according to standard procedures. Leukocytes were counted individually in these tissues and then pooled. Three-fold dilutions 11, erythropoietin (Epo), transferrin, cystine, HEPES, insulin, lipids, and 5637. Cells were plated in 1% methylcellulose as quadruplicates of pooled BM, spleen, and PB leukocytes (BM and PB, 10 4 to 10 6 cells; spleen, 10 4 to 3 1 10 5 white blood cells) were resuspended in and incubated at 37ЊC in 5% CO 2 . Total colony numbers were For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From prepared according to standard procedures. Spleen cells were enriched for T cells using enrichment columns (R&D Systems, Minneapolis, MN). LN or T-cell enriched splenocytes were resuspended in HL-1 (Hycor, Irvine, CA) media supplemented with 2% heat inactivated FCS. Cells (1 1 10 5 ) were placed in flat-bottomed 96-well plates to which phorbol 12-myristate 13-acetate (PMA)-calcium ionophore (250 ng/mL calcium ionophore and 12.5 ng/mL PMA) had been added. Proliferation in response to soluble anti-CD3 (clone 145 2C11; Pharmingen; 10, 5, 2.5, 1.25, 0.6, 0.3, and 0.15 mg/mL), Con A (5, 2, 1, 0.5, and 0.25 mg/mL), staphylococcal enterotoxin B (SEB) (S4881; Sigma), and IL-2 was tested by using a range of concentrations and time points over several days. For T-cell receptor (TCR) crosslinking, 96-well flat-bottomed plates were coated overnight with 10 mg purified goat antihamster IgG serum. Plates were washed twice before incubation with anti-CD3 (KT3; rat IgG). Cells were harvested at intervals (2 to 6 days) after a 6-to 12-hour pulse with 1 mCi of [3H]thymidine per well. Proliferation was measured by 3H-thymidine incorporation using a Matrix 96-Beta-counter (Canberra Packard, Meriden, CT). counted at day 8. Differential counts were taken 10 days after plating. Discrimination of colonies was based on colony morphology and 
Mixed lymphocyte reaction. T cells from LNs and spleens of CD44
T-cell stimulation assays. LN and spleen cell suspensions were
For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From forming units [pfu] IV). Blood was taken from tail veins on days 4, Secondary response against VSV. Mice were immunized IV with VSV (2 1 10 6 pfu, Indiana strain). After 40 and 80 days, spleen 8, and 16. Sera were tested as previously described. 68 Briefly, sera were 40-fold diluted in supplemented Dulbecco's minimal essential cells were restimulated with specific antigen by adding VSV nuclear protein class-1-binding peptide (50 mmol/L) to bulk cultures as medium (DMEM) followed by heat inactivation for 30 minutes at 56ЊC. Serial twofold dilutions were mixed with equal volumes of previously described. 70 After 5 days, in vitro cultures were harvested and tested for specific cytotoxicity against VSV-infected EL-4 (Hvirus dilutions containing 500 pfu/mL. The mixtures were incubated at 37ЊC, 5% CO 2 for 90 minutes. A total of 100 mL of each serum-2 b ) target cells. Specific lysis was calculated as described previously. Lymphocytic choriomeningitis virus (LCMV) footpad assay and virus mixture was transferred onto Vero cell monolayers in 96-well plates and incubated at 37ЊC for 1 hour. The monolayers were secondary LCMV challenge. Mice were injected with 30 mL containing 100 pfu LCMV-Armstrong strain into one hind footpad. overlayed with 100 mL DMEM containing 5% FCS and 1% methylcellulose. After an additional incubation at 37ЊC for 24 hours, the Swelling of the footpad was measured daily or every other day with a spring-loaded caliper. overlays were removed and the monolayer fixed and stained with 0.5% crystal violet. The highest dilution of serum that reduced the Mice were infected IV with 2,000 pfu LCMV-Armstrong. At day 80 the same animals were injected intracerebrally with 100 pfu number of plaques by 50% was taken as the titer. To determine IgG titers, undiluted serum was pretreated with an equal volume of 0.1 LCMV-Armstrong. Mice were monitored daily for signs of choriomeningitis and lethality. mol/L 2-ME in saline, which eliminates IgM while preserving IgG.
69
Primary ex vivo cytotoxicity assay. VSV grown in baby hamster
Contact hypersensitivity assay. Contact hypersensitivity was elicited in mice using 2,4 dinitrofluorobenzene (DNFB). In brief, 6-kidney (BHK) cells was kindly provided by Dr Lud Prevec (McMaster University, Hamilton, Ontario, Canada). Mice were infected with to 8-week-old mice were immunized on shaved abdomens with 50 mL 0.5% DNFB in 4:1 acetone/olive oil at day 0 and day 1. At day VSV (2 1 10 6 pfu, IV) and spleens were removed after 6 or 8 days. Spleen cells were incubated for 5 hours with 51 Cr-labeled EL-4 (H-5 these mice were challenged with 10 mL 0.2% DNFB in 4:1 acetone/ olive oil on the inner and outer side of one ear. Ear thickness was 2 b ) target cells, which had been infected with VSV. EL-4 cells were infected with VSV for 2 hours (15 pfu per cell) before the assay. measured 12, 24, 36, and 48 hours after reexposure and compared with the untreated ear. Specific lysis was calculated as (experimental release) 0 (spontaneous release)/(total release-spontaneous release) 1 100%.
Corynebacterium parvum. CD44 0/0 and wild-type control mice
For (C57BL/6) between 10 and 15 weeks of age were used to study C cloning cylinders. Cell lysates were separated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and Westparvum-induced granuloma formation. Granulomas were induced by a single IV injection of 7.5 mg/kg of heat-killed C parvum (Ribi ern blot analysis was performed, as previously described, by using the KM201 antimouse CD44 MoAb. Immunochem Research, Hamilton, MT). Mice were sacrificed and analyzed 2 weeks later. Liver and spleen were fixed in 10% formalin, Tumorigenicity assay. BALB/c nude mice were injected subcutaneously with 5 1 10 6 cells (5 mice/cell line). After 2 months the embedded in paraffin, sectioned, and stained with hematoxylin and eosin. Granulomas were counted in the liver at 1200 magnification mice were sacrificed and tumors measured using a caliper. Tumors were fixed in formalin and paraffin embedded sections and immunoin 10 randomly marked microscopic fields. To quantify granuloma size, the number of cells per granuloma was counted. Results are stained as previously described 73 by using an anti-SV40 large T antibody (Oncogene Science, Uniondale, NY) and the anti-CD44 expressed as the mean { standard deviation; comparisons for significance were performed using Student's t-test.
antibody KM201. The 96-well plates were covered with 0.5 mg/mL of hyaluronic and incubated overnight at 40ЊC. Plates were washed Transfection and transformation of primary fibroblasts from CD44-deficient mice. Primary fibroblasts derived from mouse emwith PBS and adhesion assay was performed as previously described 74 in the presence or absence of anti-CD44 antibody KM201. bryos were transfected with pSV3-neo (a plasmid containing the SV40 large T antigen) using lipofectin (GIBCO, Grand Island, NY). Transformed cells that survived in tissue culture after crisis were RESULTS pooled and expanded. SV40 large T-transformed fibroblasts were Generation of CD44-deficient mice. Exons 2 and 3 of infected with the murine stem cell virus (MSCV) defective retrovithe CD44 gene were disrupted by an antisense neomycin rus 71 carrying the full length mouse CD44s. 72 Infected cells were (neo) gene expression vector (Fig 1A) . Colonies of G418-selected in 150 mg/mL of Hygromycin B. Hygromycin B-resistant clones were pooled but also individual clones were isolated by using resistant embryonic stem cells were screened for homolo- For personal use only. on November 11, 2017. by guest www.bloodjournal.org From CD44 influences the formation of C parvum-induced granulomas. CD44-deficient and wild-type mice (n Å 6) were injected with 7.5 mg/ kg of heat-killed C parvum. Mice were sacrificed 14 days after injection, and liver sections were analyzed for granuloma formation. Significance was calculated by Student's t-test.
gous recombination events by the PCR, and positive clones were confirmed by genomic Southern blot analysis using a flanking probe upstream of the targeting vector. ES cell lines were also probed with neomycin using multiple restriction enzymes (data not shown). Five of the six PCR-positive colonies, which had a homologous recombination event and showed a single neo integration, were injected into blastocysts of C57BL/6 mice. The resulting chimeras were backcrossed into C57BL/6J mice. Germline transmission of the (Fig 1B) . Heterozygous offspring were bred to molecular weight markers.
obtain homozygous gene-targeted mice and further backcrossed into C57BL/6J. To confirm the absence of CD44 expression in gene-targeted mice, we examined the surface levels of CD44 on wild-type, heterozygous, and knock-out enumerated 12 days after transfer. No significant differences mice. Immunofluorescence analysis using different MoAbs were found in the number of fetal liver cells or spleen coloagainst murine CD44 was performed on leukocytes obtained nies (CD44
, 5.28 { 2.32; CD44 0/0 , 6.04 { 2.56). Similar from different organs. All MoAbs tested (IM7, KM81, results were obtained when the numbers of CFU-S d12 were KM114, and KM201) confirmed the predicted absence of determined by using cells from day 14.5 embryos (data not CD44 expression (Fig 2) , whereas a small reduction in CD44 shown). Nonetheless, other studies have suggested that interexpression levels was seen between in heterozygous mice actions between hematopoietic progenitors and stromal cells (data not shown). Heterozygous and homozygous mutant are critical for normal maturation, survival, and egress of animals were born in Mendelian ratio, survived, grew norprogenitors from BM 79, 80 and that these may involve CD44. 7 mally, and were fertile. Animals remained healthy when Thus, we also examined BM, PB, and spleen in mutant mice maintained under specific pathogen-free conditions. for hematopoietic colony forming cells and for the ability Normal organ morphology and unaltered leukocyte numto mobilize colonies after G-CSF treatment. CD44-deficient bers/lymphocyte subsets. Six-to 8-week-old mice did not mice showed reduced total numbers of CFUs in spleen and show any gross abnormalities in size, cellularity, or tissue PB (Table 1) . CFU-GM and CFU-macrophage (CFU-M) colarchitecture of major organ systems. CD44 0/0 mice showed onies were significantly reduced in the spleen (Fig 4A) . The normal hematopoiesis, and white blood cell counts were number of CFU-erythroid/burst-forming unit-erythroid comparable to controls both before and after treatment with (BFU-E), CFU-erythroid/Meg, and CFU-Mix from spleen G-CSF (Fig 3A) . Analysis of lymphocyte subsets in spleen was unchanged in mutant mice compared with heterozygous and LNs showed normal distribution and numbers of CD4 / and C8 / T cells. CD44 is normally expressed on prothymocytes 12, 75 and thymocytes, thus CD44 deficiency might be , and CD44 0/0 mice, even when suboptimal doses of anti-CD3, Con A, and SEB were used (data not shown). GM and CFU-M assays were performed at day 5 and day 7 (Fig 4B) . The total number of colonies, as well as the number Proliferation assays were also used to test allogeneic T-cell responses in mixed lymphocyte reactions (MLRs). Reof CFU-GM detected in the spleen after mobilization were again significantly reduced in mice lacking CD44, whereas sponder LN cells from CD44 28-32 Mice were inexpression fluctuates widely during B-cell development, it is conceivable that CD44 might play a role in T:B cell coopjected IV with 2 1 10 6 pfu VSV 6 days before analysis. Spleens from infected mice were removed and splenocytes eration and in Ig class switching. We investigated whether the absence of CD44 affected the level of serum Ig in mice.
incubated with 51 Cr labeled target cells infected with VSV. Contrary to expectations from previous reports, splenocytes We found mutant mice housed under pathogen-free conditions to have normal total serum Ig levels and normal levels from CD44 0/0 mice were found to mount normal ex vivo CTL responses to VSV (Fig 7A) . CD44 0/0 mice also had of the various subclasses (IgM, IgG1, IgG2, IgG2a, IgG2b, IgG3, IgE, and IgA; data not shown). This suggested that B normal survival after secondary intracerebral rechallenge with LCMV (data not shown). cells undergo normal class switching under these conditions and that cognate T:B interactions were not critically altered Additionally, CD44 expression is widely accepted as a marker for lymphocyte memory cells, 33-35 thus we used a by an absence of CD44. B-cell IgM responses against VSV do not require T helper cells, although IgG responses require VSV virus assay to assess the possible importance of CD44 in the development of memory cells. Splenocytes isolated T help and, thus, sufficient T:B cell function and interaction. As a result, analysis of responses to VSV infections can after 40 (Fig 7B) and 80 days (Fig 7C and D) from VSVinfected mice were restimulated with VSV nuclear protein provide information about both Th-dependent and Th-independent B-cell function. We injected mice IV with VSV and class-1-binding peptide in culture for 5 days. Splenocytes derived from CD44 mutant mice showed a specific cytotoxanalyzed serum samples 4, 8, and 16 days later for specific IgM and IgG levels. No differences in VSV neutralizing icity against VSV-infected EL-4 (H-2 b ) target cells that was comparable with heterozygous control mice. IgM and IgG antibodies were detectable between CD44 heterozygous and homozygous mutant animals (Fig 5) . More-CD44 0/0 mice mount delayed-type hypersensitivity (DTH) responses. Anti-CD44 MoAb treatment has been reported over, after immunization with ovalbumin and keyhole limpet hemocyanin (KLH) in the presence of incomplete or comto reduce DTH inflammatory responses in mice. 39 DTH responses require T-cell priming in draining LNs and migraplete Freund's adjuvant, no differences in specific primary and secondary IgM, IgG, and IgG1 immune responses were tion of T cells to skin. Eight-to 12-week-old mice (C57BL/ 6Jx129J) were immunized twice with DNFB and rechaldetectable at various time points (data not shown).
T-cell proliferative responses, cytotoxic T-cell function lenged after 5 days on one ear. After 12, 24, 36, and 48 hours, ear thickness was measured and compared with the (CTL), secondary restimulation, and immunological memory. CD44 has been proposed as a possible T-cell costimuuntreated ear. Homozygous-deficient mice when compared with heterozygous littermate controls showed a minor reduclatory molecule. 14, [23] [24] [25] [26] [27] 81 We examined whether T cells from For tion of ear swelling, although the difference was not statisti-CD44 regulates tumorigenicity of fibroblasts. To study the potential role of CD44 in malignant transformation, we cally significant (Fig 8A) . Swelling reactions were also normal in mice after footpad infection with LCMV (Fig 8B) .
transfected primary fibroblasts derived from the intestine of CD44-deficient mice with the SV40 large T antigen. To Exaggerated granuloma response to C parvum. C parvum is an intracellular parasite that normally induces granucompare the effect of CD44 in the same genetic background, CD44-positive fibroblasts were generated by infecting the loma formation in tissues of infected animals. Moreover, cell-mediated immunity and granuloma formation are likely SV40 large T-transformed fibroblasts with a defective retrovirus carrying the full length mouse CD44s cDNA. Anticritical to recovery from C parvum infection. 82, 83 We injected heat-killed C parvum to specifically assess granuloma re-CD44 MoAb detects a band of the expected molecular weight in the pooled infected cells and in an independently sponses of mutant mice to C parvum. CD44-deficient mice developed a statistically significant 1.71-fold greater number derived single clone (Fig 9) , which is not seen in a pooled population of CD44-negative fibroblasts infected with a retof granulomas compared with wild-type controls. Granulomas were also larger in mutant mice (Table 2) . rovirus control; moreover, CD44-transfected fibroblasts
For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From Fig 10 (cont'd) .
showed significantly better attachment to HA compared with -negative tumors expressed similar levels of SV40 large T antigen (Fig 10) . Histologically both tumors were similar, CD44 0/0 cells (Table 3) . We did not detect any obvious differences in the morphology or in the in vitro growth propalthough CD44-negative tumor cells showed more cellular pleomorphism and had a higher mitotic index. erties between CD44-negative and -positive fibroblasts. CD44-negative fibroblasts gave rise to large subcutaneous DISCUSSION tumors that forced us to sacrifice mice after 2 months. However, the CD44-positive fibroblasts gave rise to very small
The expression of CD44 molecules is modulated during the development and activation of a large variety of cell and tumors over the same period of time (Table 4) . Tumor sections were stained for SV40 large T antigen and CD44.
tissue types. Given the extensive expression of CD44 during embryogenesis, we anticipated that mice lacking CD44 The small tumors derived from CD44-containing fibroblasts retained CD44 expression, and both CD44-positive and might die during embryonic stages of development or that
For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From they might manifest some form of developmental detypes. 58, 89, 90 It is conceivable that CD44 may be involved in either the production or delivery of cytokines that could be fects. [4] [5] [6] To our surprise, CD44-deficient mice backcrossed important in the regulation of cell:cell interaction and in the into C57BL/6 were born healthy in a Mendelian ratio and tissue distribution of CFU-GM progenitors. developed normally. No gross deficits in neurological func-CD44 is expressed on erythropoietic progenitors. Kansas tion or behavior were apparent. et al 11 reported high levels of CD44 on early progenitor During hematopoiesis, CD44 is highly expressed on early cells capable of erythroid development and observed CD44 myeloid cells and downregulated during commitment to downregulation during erythroid differentiation. More regranulopoiesis. 11 In addition, it has been shown that in BM cently, Ghaffari et al 10 found that the majority of BM cells cells sorted into CD44 high and CD44 low populations, only the capable of differentiating into BFU-E were CD44 / , although CD44 high expressing cells are able to form CFU-GM coloexpression levels were not high and were not downregulated nies. 8 The presence of CD44 MoAbs in Dexter-type longduring differentiation. In our experiments, we did not see a term BM cultures was shown to prevent the emergence of significant difference in the number of erythrocytes (red myeloid cells, most likely the result of blocked attachment blood cells) or BFU-E colonies in CD44-deficient animals and interaction between stromal cells and hematopoietic procompared with controls. As a consequence, we cannot progenitors. 7 More recently, it has been shown that anti-CD44 vide any evidence that would suggest a critical role for CD44 antibodies as well as antibodies against VLA-4 (alpha 4/ in erythroid development. beta 1-integrins) can block the formation of cell adhesion Fetal or BM thymocyte progenitors display a fluctuating to fibronectin, an important molecule on BM stromal cells expression of CD44 during thymocyte ontogeny. 12, [76] [77] [78] It has involved in the attachment of hematopoietic progenitors. 9 been reported that the binding of prothymocytes to the thyHowever, CD44-deficient mice do not show a significant mus endothelial cells is mediated through the interaction of reduction in the total numbers of white blood cells or granu-CD44 and that anti-CD44 antibodies can block colonization locytes in the PB. Furthermore, there was no significant of the thymus. 14,75 Thus, we had reasonable expectations difference in the number of hematopoietic progenitor cells that CD44-deficient mice might have abnormal numbers of in the fetal liver of CD44 0/0 mice. Finally, there was normal thymocytes or thymocyte subsets. No such defects were seen engraftment of CD44-deficient fetal liver cells into the spleen in CD44-deficient mice. However, in same report by Patel of wild-type recipients, indicated by comparable numbers of et al, 75 it was found that, in addition to CD44, b-1 integrins fetal liver-derived CFU-S colonies.
on immature T cells interact with fibronectin on endothe-CD44-deficient mice showed a defect in the distribution of lium; clearly this interaction may compensate for a lack of granulocyte-macrophage progenitor cells between BM and CD44 during T-cell development. It is still possible that spleen. There were significantly lower numbers of CFU-GM undetectable defects in thymocyte-positive or -negative secolonies in the spleen as well as in the PB. Interestingly, this lection might become obvious when the CD44 mutation is phenotype became more prominent after stimulation with Gintroduced into TCR transgenic backgrounds, where highly CSF. At the same time, whereas CFU-GM were reduced exaggerated frequencies of specific T cells can be subjected from PB and spleen, the numbers of these progenitor cells to positive or negative selection in vivo. 91 were elevated from BM of mutant animals. Thus, despite CD44 has been reported to be costimulatory in combinareduced numbers of GM progenitors in blood and spleen, tion with CD2 and/or the TCR complex (CD3), although the accumulation in BM leads us to the conclusion that CD44 other studies have not observed costimulation with CD44/ deficiency probably causes an altered distribution of GM CD3 and have reported inhibitory effects after CD44 stimuprogenitors rather than a general defect in maturation. An lation. 24, 92, 93 In addition, CD44 has been found to augment earlier report suggested that galactosyl and mannosyl struc-CD28 costimulation in T cells, most likely in an IL-2-indetures on the surface of CFU-GM might be involved in interpendent fashion. 94 Nonetheless, activation of T cells is probaactions between CFU-GM and marrow stromal cells. 84 These bly triggered for the most part by TCR interactions with the interactions may include CD44 and be important in deantigen-major histocompatibility complex (MHC), perhaps termining the egress of CFU-GM from BM.
in combination with binding of the CD4/CD8 coreceptors Although the maturation of CFU-GM in BM appears not and CD28. Thus, we were not surprised to see normal T-cell to require stimulation through the CD44 receptor, such sigproliferative responses to various mitogenic stimuli, such as naling may be required for the normal release or distribution anti-CD3, PMA-Ca ionophore, SEB, and allogeneic cells. In of cytokines in spleen or PB. Three lines of evidence support our mutant mice, we could not detect a major costimulatory a role for CD44 in regulating cytokine release and distriburole for CD44, although such a function could well be comtion. (1) It has been shown that stimulation through the CD44 pensated by other molecules, especially CD28. receptor can induce production of a number of different
The invariant chain (Ii) can be postranslationally modified growth factors, including M-CSF, tumor necrosis factor-a by the addition of chondroitin sulfate (Ii-CS) before it associ-(TNFa), interferon-g (IFN-g), insulin-like growth factor-1, ates with class II MHC molecules. CD44 binds Ii-CS, apand TNFb. [85] [86] [87] [88] (2) Certain cytokines (ie, MIP-1b, b-FGF, pears to augment the accessory function of Ii-CS, and may and HB-EGF) bind glycosaminoglycans, increasing the posbe involved in class II-dependent allogeneic and mitogenic sibility that glycosaminoglycans on CD44 might compete T-cell responses. 95 In MLRs using CD44 0/0 (C57BL/6 backwith cytokines and, therefore, regulate cytokine binding to ground) splenocytes as stimulators, we found no significant surrounding cells. 
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Further reports have suggested a role for CD44 in CTL, however, studies of human epidermal skin tumors find that neither qualitative nor quantitative changes in CD44 splicewhich may reflect the ability of CD44 to enhance IFN-g, TNFa, and TNFb production. After infection with VSV and variant expression correlate with invasive or metastatic potential. Rather, the report suggests that CD44 isoform ex-LCMV, we saw no reduction in CTL in CD44-deficient mice. In vitro and in vivo results 40 and 80 days postinfection also pression varies with the degree of tumor differentiation. 117 Correlation between the stage of tumor differentiation and suggested that CD44 did not have a critical role in generating T-and B-memory lymphocytes. We further investigated CD44 expression has been reported elsewhere. [118] [119] [120] The mechanism by which CD44s inhibits tumorigenicity has not CD4 and CD8 T-cell function using DTH tests with DNFB and LCMV. These reactions require migration of antigen been deciphered, but our results seem to indicate that this mechanism only operates in vivo. Because it has been representing cells into draining LNs, recirculation of CD4 and CD8 T lymphocytes into LNs, and lymphocyte proliferation ported that the engagement of CD44 can induce the release of cytokines, 121 it is tempting to speculate that in fibroblasts and migration into skin or footpads. DTH was not significantly reduced in CD44 mutant mice, indicating that other this might alter the interaction of tumor cells and surrounding stroma and result in an inhibitory effect on tumor growth. adhesion molecules (ie, selectins and b-2 integrins) play a greater role in DTH responses. 96, 97 Moreover, the ability of Overall, we were surprised about the moderate phenotype of the mice lacking CD44, particularly in regard to embryogenesis. T cells to regulate and help B cells appeared to be normal in CD44-deficient mice, as evidenced by normal levels of Reports about stimulation, proliferation and other effects modulated by anti-CD44 antibody treatment might be characteristic all Ig classes and subclasses in untreated mice (data not shown), as well as normal Th-dependent IgG responses to of the in vitro nature of the assays, especially when complete antibodies were used, or might reflect nonspecific effects of VSV and KLH. It should be noted that the peripheral T cells in C57BL/6 mice have lower levels of CD44 compared with antibody treatment, such as capping of other crucial surface molecules or even killing of CD44 expressing cells, effects that the BALB/c mouse strain, which express the CD44.2 and CD44.1 alleles, respectively. 34,76,98-101 T cells in the C57BL/ are possibly very useful in the treatment of disease. On the other hand, it is possible that there is some compensation by 6 strain may use molecules that functionally compensate for lower CD44 expression. To investigate this, at least ten other adhesion molecules like selectins and lectins in the absence of CD44 122,123 and overlapping functions, especially mebackcrosses into BALB/c background are necessary. This is currently under way.
diated by other hyaluronan-binding proteins like neurocan, versican, aggrecan, link protein, TSG6, and RHAMM with The granuloma is the central defense mechanism against intracellular bacteria: The failure to develop adequate granustructural similarity to CD44.
